SEC Form 4 · accession 0001209191-17-065216
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hans Peter Hasler
Director
Period of report
Dec 10, 2017
Accepted (ET)
Dec 12, 2017 · 4:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option Grant (Right to Buy)F1 | $5.70 | Dec 10, 2017 | A | 40,000 | A | — | Dec 10, 2027 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The shares subject to this option will vest in equal monthly installments commencing on the date one month following December 10, 2017, subject to the continued service of the Reporting Person as a non-employee director as of such vesting date.